Related Experiment Video
Updated: May 18, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Effect of inflammation on molecular targets and drug transporters
Sherif Hanafy1, Ayman O S El-Kadi, Fakhreddin Jamali
1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
Inflammation, the host's response to infection and injury, is associated with altered expression of genes such as metabolizing enzymes, transporters, receptors and plasma proteins. The purpose of the present work was to characterize the effect of inflammation on selected molecular targets and transporters that affect drugs' action and disposition. We have used rats with adjuvant arthritis (AA), an animal model of chronic inflammation. The AA group received 0.2 ml of 50 mg ml-1 Mycobacterium butyricum suspended in squalene into the tail base. On day 12, the rats were euthanized and their organs (heart, liver, kidneys and intestine) excised. Expression of Cav1.2, β1-AR, β2-AR, α1A-AR, Nav1.2, Nav1.6, Kv1.5, Kv2.1, Kv3.1, oatp1a1, oatp1a5, oatp1b2, oatp2b1, oatp4a1, oat2, oat3, oct1, mdr1a, bsep, mrp1, mrp3, mrp6, IL-1α, IFN-γ, iNOS, MCP-1, IL-10, Cox-1 and Cox-2 were determined by real time polymerase chain reaction (RT-PCR). Inflammation resulted in a significant reduction of oct1, oatp4a1 and mrp1 gene expression in the liver and oatp2b1, mrp6 and bsep gene expression in the kidney. Oatp4a1 and mdr1a were found to be significantly upregulated in rat heart. In conclusion, inflammation alters the gene expression of some mediators and drug transporters that can influence the behavior of drugs in the body and contribute to therapeutic failure.
Insights
Inflammation significantly alters gene expression of drug transporters in rat organs, impacting drug disposition and potentially leading to therapeutic failure. This study highlights key changes in liver, kidney, and heart transporter expression during chronic inflammation.
Area of Science:
- Pharmacology
- Molecular Biology
- Immunology
Background:
- Inflammation, a biological response to infection or injury, alters the expression of various genes, including those involved in drug metabolism and transport.
- Understanding these alterations is crucial for predicting drug efficacy and managing potential therapeutic failures in inflammatory conditions.
Purpose of the Study:
- To investigate the impact of chronic inflammation on the gene expression of specific drug transporters and molecular targets.
- To characterize how inflammation affects drug action and disposition by examining changes in transporter expression in key organs.
Main Methods:
- Utilized a rat model of adjuvant arthritis (AA) to induce chronic inflammation.
- Quantified the gene expression of numerous drug transporters and inflammatory markers in heart, liver, kidneys, and intestine using real-time polymerase chain reaction (RT-PCR).
Main Results:
- Significant downregulation of organic anion transporting polypeptide 4a1 (oatp4a1), organic cation transporter 1 (oct1), and multidrug resistance-associated protein 1 (mrp1) gene expression was observed in the liver.
- Kidney exhibited significant reductions in oatp2b1, mrp6, and bile salt export pump (bsep) gene expression.
- Oatp4a1 and multidrug resistance 1a (mdr1a) gene expression were significantly upregulated in the rat heart.
Conclusions:
- Chronic inflammation demonstrably alters the gene expression profiles of critical drug transporters in various organs.
- These changes in transporter expression can significantly influence drug pharmacokinetics and pharmacodynamics.
- The observed alterations may contribute to reduced drug efficacy and therapeutic failure in patients with inflammatory diseases.
Related Concept Videos
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Acute Inflammation III: Local and Systemic Effects
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Inflammation
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Chronic Inflammation: Introduction

